Overview
A large number of women are told they cannot have hormone therapy because they get migraines — particularly migraine with aura. That advice is frequently based on guidance about contraception, which is a different treatment with a different estrogen at a much higher dose.
The distinction matters enough to state plainly.
| Combined hormonal contraception | Menopausal hormone therapy | |
|---|---|---|
| Estrogen used | Ethinylestradiol, synthetic | Estradiol, identical to the body's own |
| Amount | Substantially higher — designed to suppress ovulation | Lower — designed to replace |
| Migraine with aura | Generally avoided — stroke risk concern | Not generally a contraindication, particularly transdermal |
| Preferred route if used | — | Transdermal, for steadier levels and no hepatic first pass |
Where current guidance lands: migraine, including migraine with aura, is not generally considered a contraindication to menopausal hormone therapy, and transdermal estradiol is the preferred route. That is a meaningful difference from contraceptive advice, and it is worth raising specifically if you have been told otherwise.
None of which makes this a decision to make from an article. Migraine with aura does carry an independent stroke risk, other risk factors matter alongside it, and this belongs in a proper consultation.
Why migraine and hormones are connected at all
Migraine is roughly three times more common in women than men after puberty, and the pattern tracks hormonal events across a lifetime — which is the clue to the mechanism.
Falling estrogen is the trigger, more than any absolute level. Menstrual migraine typically occurs in the days around the drop before a period. Migraine often improves in pregnancy, when estrogen is high and stable, and frequently worsens in perimenopause, when levels fluctuate erratically.
That is why stability matters more than quantity in this context. A steady level is generally better tolerated than a fluctuating one, and this is the single most useful principle for anyone managing both at once.
Many women find migraine improves after menopause once the fluctuation settles — though this is not universal, and some find the opposite.
Why the route matters here specifically
Two reasons, and both point the same way.
Steadier levels. A transdermal patch or gel delivers estradiol continuously, avoiding the peaks and troughs of daily oral dosing. Since it is the fall in estrogen that triggers migraine, a steady delivery is less provocative than a fluctuating one.
No hepatic first pass. Oral estrogen passes through the liver at high concentration and increases production of clotting factors. Since the concern with migraine with aura is stroke risk, avoiding an additional prothrombotic effect is the sensible choice. How the routes differ across the board.
Continuous rather than cyclical regimens are also often preferred for the same stability reason, where they are otherwise appropriate.
Migraine with aura and stroke risk — the honest picture
This is the part that needs stating carefully rather than reassuringly.
Migraine with aura is independently associated with an increased risk of ischemic stroke. That association is real, it exists whether or not you take anything, and it is the basis for the caution around combined hormonal contraception.
The absolute risk in an otherwise healthy woman is low, and it is compounded by other factors — smoking in particular, which combines with migraine with aura to raise risk considerably more than either alone. Stopping smoking is the single most valuable thing available to anyone in this situation.
What current menopause guidance concludes is that menopausal hormone therapy, particularly transdermal, does not carry the same concern as combined contraception, because the estrogen and the amounts are different. That is the position — and it is a position about a population, not a substitute for assessing you.
Which is why this is a consultation rather than a rule. Your aura frequency and pattern, your blood pressure, whether you smoke, your other cardiovascular risk factors and your family history all enter the assessment.
What should be assessed
Whether you actually have aura, and what it consists of. Visual disturbance before a headache is the common form. Many women who describe "aura" are describing prodromal symptoms, which is a different thing, and the distinction changes the conversation.
Blood pressure, controlled before starting. Why the route matters here too.
Smoking status, which is the most consequential modifiable factor in this picture.
Other cardiovascular risk — lipids including ApoB, glucose, weight, family history.
Your current migraine pattern, so that any change after starting can be recognized as a change rather than lost.
And a red flag worth naming: a new aura, an aura that has changed in character, an aura lasting longer than about an hour, or aura without headache appearing for the first time — all warrant assessment rather than adjustment. So does the worst headache of your life, or a headache with weakness, speech difficulty or visual loss, which needs urgent attention.
If migraine changes after starting
Not unusual, and not automatically a reason to stop.
Worsening may respond to a route change, to moving from cyclical to continuous, or to an adjustment your prescriber can make. It is worth reporting rather than enduring or abandoning treatment over.
Improvement is also common, particularly where erratic perimenopausal fluctuation was driving it.
A new or changed aura is the exception — that is a reason for assessment rather than adjustment.
Frequently asked questions
Can I take HRT if I get migraines with aura? Migraine with aura is not generally considered a contraindication to menopausal hormone therapy, and transdermal estradiol is preferred. This differs from contraceptive guidance, which concerns a different, higher-dose synthetic estrogen.
Why was I told I could not? Frequently because contraceptive guidance was applied to menopausal hormone therapy. They are different treatments with different estrogens at different doses.
Which route is best? Transdermal — steadier levels, and no first-pass hepatic effect on clotting factors. Continuous rather than cyclical is often preferred for the same stability reason.
Will HRT make my migraines worse? It can go either way. Erratic perimenopausal fluctuation often drives migraine, and a steady level sometimes improves it. Worsening is worth reporting, since a route or regimen change may resolve it.
What if I get a new aura after starting? That warrants assessment rather than adjusting on your own — as does an aura that has changed in character or lasts unusually long.
Where this fits in your plan
If you have been turned down for hormone therapy because of migraine, it is worth asking specifically whether that was based on contraceptive guidance — because for menopausal hormone therapy the position is different.
That said, this is a genuine risk conversation and not a formality. It needs your migraine pattern, your blood pressure, your smoking status and your cardiovascular risk in front of someone. What we assess, and what hormone therapy with us involves.
We measure first. Then we act.
Ready to start your second act?
It starts with measuring, not guessing. A short, clinician-reviewed assessment shows what fits you.
This article is educational and is not medical advice. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. Individual results vary.
